Cargando…
Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction
The beta blockers carvedilol, bisoprolol, and sustained-release metoprolol succinate reduce readmissions and mortality among patients with heart failure with reduced ejection fraction (HFrEF), based upon clinical trial and registry studies. Results from these studies may not generalize to the typica...
Autores principales: | Loop, Matthew Shane, Van Dyke, Melissa K., Chen, Ligong, Brown, Todd M., Durant, Raegan W., Safford, Monika M., Levitan, Emily B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347167/ https://www.ncbi.nlm.nih.gov/pubmed/32645049 http://dx.doi.org/10.1371/journal.pone.0233161 |
Ejemplares similares
-
Causes and Temporal Patterns of 30‐Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction
por: Goyal, Parag, et al.
Publicado: (2018) -
Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
por: Miñana, Gema, et al.
Publicado: (2022) -
Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database
por: Jha, Anil Kumar, et al.
Publicado: (2022) -
Systolic Strain Abnormalities to Predict Hospital Readmission in Patients With Heart Failure and Normal Ejection Fraction
por: Borer, Steven M., et al.
Publicado: (2011) -
Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
por: Nishino, Masami, et al.
Publicado: (2021)